2008 Vol.26, N°5 - Suppl.51 - Table of contents

Mortality in Rheumatic Diseases

Guest Editors: T. Sokka, T. Pincus

CME Credit are available through the New York University.

This issue is valid for obtaining a maximum of 9.0 CME credits. Each physician should claim only those credits that he/she actually spent in the activity.

To receive the CME credits, for US physicians, please go to page S141-S145.

The Journal thanks Abbott Laboratories, Amgen & Wyeth Pharmaceuticals, Bristol-Myers Squibb, Inc., Centocor Inc., Genentech/Biogen IDEC, Pfizer, Inc., for support of this Supplement.

purchase complete issue

Continuing Medical Education Activity

CER3414
2008,26,5,Suppl.51
Pg. 0000

Free to view

Information
***

Introduction

CER3396
2008,26,5,Suppl.51
Pg. 0001-0004

Free to view

Mortality in rheumatic diseases: introduction
T. Pincus, T. Sokka

General issues in mortality

CER3395
2008,26,5,Suppl.51
Pg. 0005-0013

Free to view

Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
I. Avalos, Y.H. Rho, C.P. Chung, C.M. Stein

CER3397
2008,26,5,Suppl.51
Pg. 0014-0020

Free to view

Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases
T. Sokka, A. Häkkinen

CER3398
2008,26,5,Suppl.51
Pg. 0021-0024

Free to view

Should an order to “monitor long-term vital signs,” including mortality outcomes, be as routine as an order for a laboratory test in patients with rheumatic diseases?
T. Pincus, T. Sokka

CER3399
2008,26,5,Suppl.51
Pg. 0025-0034

Free to view

Limitations of a biomedical model to explain socioeconomic disparities in mortality of rheumatic and cardiovascular diseases
B. Abelson, A. Rupel, T. Pincus

Mortality in specific rheumatic diseases

CER3400
2008,26,5,Suppl.51
Pg. 0035-0061

Free to view

Mortality in rheumatoid arthritis: 2008 update
T. Sokka, B. Abelson, T. Pincus

CER3401
2008,26,5,Suppl.51
Pg. 0062-0065

Free to view

Mortality in psoriatic arthritis
D.D. Gladman

CER3402
2008,26,5,Suppl.51
Pg. 0066-0071

Free to view

Mortality in Sjögren’s syndrome
M. Voulgarelis, A.G. Tzioufas, H.M. Moutsopoulos

CER3403
2008,26,5,Suppl.51
Pg. 0072-0079

Free to view

An update on mortality in systemic lupus erythematosus
A. Ippolito, M. Petri

CER3404
2008,26,5,Suppl.51
Pg. 0080-0084

Free to view

Mortality in ankylosing spondylitis
J. Zochling, J. Braun

CER3405
2008,26,5,Suppl.51
Pg. 0085-0093

Free to view

Mortality in systemic sclerosis
F.B. Karassa, J.P.A. Ioannidis

CER3406
2008,26,5,Suppl.51
Pg. 0094-0104

Free to view

Mortality in systemic vasculitis: a systematic review
R. Phillip, R. Luqmani

CER3407
2008,26,5,Suppl.51
Pg. 0105-0108

Free to view

Mixed cryoglobulinemia and mortality: a review of the literature
A. Della Rossa, F. Marchi, E. Catarsi, A. Tavoni, S. Bombardieri

CER3408
2008,26,5,Suppl.51
Pg. 0109-0114

Free to view

Mortality in idiopathic inflammatory myopathies
I.E. Lundberg, C.J. Forbess

CER3409
2008,26,5,Suppl.51
Pg. 0115-0119

Free to view

Gout and mortality
S.Y. Kim, M.A. De Vera, H.K. Choi

CER3410
2008,26,5,Suppl.51
Pg. 0120-0124

Free to view

Mortality in osteoarthritis
M. C. Hochberg

CER3411
2008,26,5,Suppl.51
Pg. 0125-0137

Free to view

Mortality and osteoporotic fractures:is the link causal, and is it modifiable?
G.G. Teng, J.R. Curtis, K.G. Saag

CER3412
2008,26,5,Suppl.51
Pg. 0138-0140

Free to view

Mortality in Behçet’s syndrome
H. Yazici, F. Esen

Continuing Medical Education Activity

CER3413
2008,26,5,Suppl.51
Pg. 0141-0145

Free to view

Information and Test
***